ReviewMedicine2025

Usage of brolucizumab as treatment for wet age-related macular degeneration (AMD) and polypoidal choroidal vasculopathy (PCV): A narrative review.

Siti Nursyazanie Jezani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.